GlaxoSmithKline PLC ADR
I · KI-Analyse
Kurzfassung
GSK develops and sells vaccines for diseases like RSV, shingles, flu, and HPV, plus specialty treatments for cancer, HIV, and respiratory conditions, and everyday medicines for asthma and infections [COMPANY OVERVIEW]. The company operates globally with manufacturing and research facilities, selling through hospitals, clinics, and pharmacies in over 100 countries. GSK also collaborates with partners like CureVac on mRNA vaccine technology and AN2 Therapeutics on tuberculosis therapies [COMPANY OVERVIEW].
GSK is a major UK-headquartered pharmaceutical company that makes vaccines (RSV, flu, shingles, meningitis), specialty medicines (oncology, HIV, respiratory), and general medicines (asthma, COPD, antibiotics) [COMPANY OVERVIEW]. With $32,7 billion in revenue and a 17,5% net margin, the company is financially healthy and generates $5,8 billion in free cash flow annually [Yahoo Finance]. Recent news shows Japan expanded approval for GSK's RSV vaccine Arexvy to younger at-risk adults, opening a larger market [Nasdaq].
GSK is financially strong with solid profitability, low debt, and healthy cash generation.
Sentinellis-Score
7,9/10
Finanziell gesund
Marktkapitalisierung
$102,4B
Umsatz (12 Monate)
GBP 32,7B
Erklärt
Wie wir diese Zahlen lesen
Verständliche Leitfäden · ohne Konto
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LesenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LesenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LesenII · Aktuelle Nachrichten
Was den Kurs bewegt hat
1 Meldung · nach Relevanz sortiert
- Makro2026-05-18
GSK: Japan's MHLW Expands Eligible Population For Arexvy
Nasdaq
Premium · kostenlos mit jedem Konto
Dodge & Cox, the second-largest institutional holder at 2,92% of the company, cut its stake by 14,4% in the most recent quarter, a meaningful reduction that could signal concerns about near-term performance or valuation [EODHD].
Risiken
4
Chancen
4
Warnsignale
1
Führung
10
8 weitere Erkenntnisse im vollständigen Bericht — kostenlos mit jedem Konto.
Vollständige GlaxoSmithKline PLC ADR-Analyse freischalten
Erstellen Sie ein kostenloses Konto für den vollständigen KI-Bericht mit Quellenangaben im Text.
- 4 Risiken, 4 Chancen und 1 Warnsignal — jeweils mit Quelle
- Über 100 Finanzkennzahlen mit Charts und Vergleichen
- Vollständige Nachrichten-Zusammenfassungen mit Quellenlinks
- Führungsteam und Vergütung
III · Ähnliche Unternehmen
Das könnte Sie auch interessieren
Gleicher Sektor · Gesundheitswesen — oder vergleichbare Finanzlage
Auf Ihre Watchlist setzen?